ArticleAmerican journal of hematology2026

Real-World Usage and Outcomes of Different Siltuximab Dosing Frequency in Idiopathic Multicentric Castleman Disease.

Yoshito Nishimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.